2014 Fall CLU Highlights

Enzyme Replacement Therapy for Lipid Storage Disorders

Faculty: W. Virgil Brown, MD, Robert J. Desnick, PhD, MD, and Gregory A. Grabowski MD

Tags:

W. Virgil Brown, MD, Robert J. Desnick, PhD, MD, and Gregory A. Grabowski, MD discuss JCL Roundtable: Enzyme replacement therapy for lipid storage disorders.

Summary

pdf

MP3 Audio

No votes yet

Advancing Therapy in the Severe FH Patient

Faculty: Anne Carol Goldberg, MD, FACP, FAHA, FNLA, Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA, and James A. Underberg MS, MD, FACP, FACPM,FNLA

Tags:

Anne Carol Goldberg, MD, FACP, FAHA, FNLA presents Identification of the Patient with Familial Hypercholesterolemia: Genotypic and Phenotypic Considerations.

Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA presents Clinical Evaluation of the Severe FH Patient and Treatment Considerations.

James A. Underberg MS, MD, FACP, FACPM,FNLA presents New Treatments for Homozygous Familial Hypercholesterolemia .

play

pdf

MP3 Audio

No votes yet

NLA Recommendations for Patient-Centered Management of Dyslipidemia

Faculty: Carl E. Orringer, MD, FACC, FNLA

Tags:

Carl E. Orringer, MD, FACC, FNLA presents NLA Recommendations for Patient-Centered Management of Dyslipidemia.

play

pdf

MP3 Audio

No votes yet

Data Supported Evidence for Differences in the ACC/AHA Guidelines and NLA Recommendations for Dyslipidemia Management

Faculty: Kevin C. Maki, PhD, CLS, FNLA

Tags:

Kevin C. Maki, PhD, CLS, FNLA presents Data Supported Evidence for Differences in the ACC/AHA Guidelines and NLA Recommendations for Dyslipidemia Management.

play

pdf

MP3 Audio

No votes yet